Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes.

Dhurandhar, Nikhil V; Akheruzzaman, Md; Hegde, Vijay

Dhurandhar, Nikhil V; Akheruzzaman, Md; Hegde, Vijay.

Dhurandhar NV; Department of Nutritional Sciences, Texas Tech University, Lubbock, TX, 79409, USA. Nikhil.Dhurandhar@TTU.EDU.
Akheruzzaman M; Department of Nutritional Sciences, Texas Tech University, Lubbock, TX, 79409, USA.
Hegde V; Department of Nutritional Sciences, Texas Tech University, Lubbock, TX, 79409, USA.

Nutr Diabetes ; 10(1): 30, 2020 08 12.

Article in English | MEDLINE | ID: covidwho-713236

Subject(s)

Betacoronavirus; Coronavirus Infections/etiology; Diabetes Mellitus, Type 2/complications; Pneumonia, Viral/etiology; Angiotensin-Converting Enzyme 2; COVID-19; Coronavirus Infections/mortality; Humans; Pandemics; Peptidyl-Dipeptidase A/physiology; Pneumonia, Viral/mortality; SARS-CoV-2; Severity of Illness Index

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Diabetes Mellitus, Type 2 / Betacoronavirus Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Nutr Diabetes Year: 2020 Document Type: Article Affiliation country: S41387-020-00133-0

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google